Anzeige
Mehr »
Login
Montag, 10.08.2020 Börsentäglich über 12.000 News von 643 internationalen Medien
Spannend! Billiarden-Karten werden auf den Tisch gelegt.
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

Aktuelle News von Xconomy

  • 24 h
  • letzte 200 News
ZeitAktuelle Nachrichten
13:31Seres Sets Sights on FDA After C. Diff Microbiome Therapy Scores in Phase 3
SaFDA Green-Lights Roche Spinal Muscular Atrophy Drug, First Oral Therapy
FrAbbVie Exits Editas Alliance, Pruning Another Genetic Medicines Pact
FrBio Roundup: A Telehealth Combo, FDA's BCMA OK, Biogen's Bet & More
FrModerna, Pfizer Protocols May Make COVID Vaccines Hard to Compare
FrGlaxoSmithKline Multiple Myeloma Drug Earns FDA's First Anti-BCMA Nod
DoG1 Vets Launch Arc Therapeutics to Take on New Cancer Target
DoBiogen to Pay Denali $1B to Partner on Parkinson's Drug & Other Neuro Meds
MiIgGenix Grabs $10M to Advance Antibody Treatments for Allergies
MiAs Patients Pivot to Telehealth, Teladoc & Livongo Plan $18.5B Tie-Up
MiGentiBio Joins Cell Therapy Chase With $20M and New Treg Technology
MiStill Stuck on Adhesion Issues, FDA Rejects DBV's Peanut Allergy Patch
DiCymaBay PBC Drug Hits Phase 3 Goals With Signs of Side Effect Advantage
DiAbbVie Walks From Voyager R&D Pact Spanning Alzheimer's, Parkinson's
03.08.MorphoSys, Incyte Get Early FDA Nod for Antibody Alternative to CAR-T
01.08.Kymera Therapeutics Unveils IPO Pitch for Protein Degradation
31.07.Bio Roundup: Cerevel's Shell, Thrive's Rise, Drug Price Drama & More
31.07.Novartis Pays $75M to Get Hands on Sangamo's Zinc Fingers for Drug R&D
30.07.AlloVir's IPO Raises $276M to Test Cell Therapies in Transplant Patients
30.07.Amid Boom Days for Biotech, Inhibrx Lines Up Another IPO Effort
29.07.Roche Pays $120M for Rights to UCB's Tau-Targeting Alzheimer's Drug
29.07.2020 National Xconomy Awards Finalists Announced
29.07.Omega Therapeutics Lands $85M to Tap Into "Control Room" for Biology
29.07.Nura Bio Debuts With $73M and Plan to Develop "Neuroprotective" Drugs
29.07.Thrive Adds $257M, Plans Pivotal Trial of Early Cancer Detection Test